CureSearch for Children's Cancer funds and supportstargeted and innovative children's cancer research with measurableresults, and is the authoritative source of information and resourcesfor all those affected by children's cancer.
A great deal of progress has been made in treating Wilms tumor over the last 25 years. Nine out of ten children are successfully treated with surgery, chemotherapy and sometimes radiation therapy.
Many improvements in treatments have resulted from the work of the Children's Oncology Group (formerly the National Wilms Tumor Study Group). Today, most children with Wilms tumor are enrolled and treated in a clinical trial, so that the best treatments available can be improved even further.
Wilms tumors are relatively rare, therefore it is important to seek care at an experienced children’s cancer center. A team approach that includes the child's pediatrician as well as specialists at the children’s cancer center where the treatment will be provided is recommended. Once a Wilms tumor is discovered, children should begin treatment quickly. Wilms tumors are often quite large by the time they are discovered, and these tumors tend to grow rapidly.
The first goal is to remove the tumor from the involved kidney or major site, even if the cancer has spread (metastasized) to other parts of the body. Sometimes, the tumor can be too large to remove immediately and may have spread into nearby blood vessels, other vital structures, or may be found in both kidneys. In these patients, doctors sometimes use chemotherapy to shrink the tumor before removing it later in the course of therapy.
SurgerySurgery is the main treatment for Wilms tumor. The most common operation for Wilms tumor is called a radical nephrectomy. In this procedure, a surgeon removes the cancer along with the entire kidney, the ureter (the tube that carries urine from the kidney to the bladder), and fatty tissue that surrounds the kidney.
At the time of the radical nephrectomy, a regional lymph node sampling is performed. In this procedure, the surgeon removes the lymph nodes next to the kidney. Lymph nodes are bean-sized glands that are part of the immune system and help to fight infections. Many cancers spread to the lymph nodes. Sampling the lymph nodes helps assess thedegree of spread within the abdomen.
During surgery, the liver and the other kidney will also be examined. Any suspicious areas may be biopsied, meaning that tissue samples are removed for examination under a microscope.
If imaging tests such as a chest x-ray or CT scan suggest that the Wilms tumor has spread to the lungs, the surgeon may also take a tissue sample or remove the nodule completely. This may be done through a separate incision in the chest wall using a special operating telescope. This procedure is called Video Assisted Thoracoscopic Surgery (VATS) and can be used to remove tumors in the lung with minimally invasive techniques.
Knowing whether or not a Wilms tumor has spread to the lymph nodes, liver or the other kidney is important in determining the stage of the disease, as well as in choosing treatment.
Chemotherapy medications are injected into a vein in different combinations and dosages at different times, depending on the type and stage of Wilms tumor. Chemotherapy is ordered by the pediatric oncologist and is usually given by a nurse. Most chemotherapy for Wilms tumor can be given in an outpatient setting; however, in some cases the patient must be hospitalized.
While chemotherapy kills cancer cells, it can also damage some normal cells. Careful attention is given to avoid or minimize side effects. The side effects of chemotherapy depend on the type of drugs, the amount taken and the length of time they are taken. It is important to tell the cancer care team if the child has any side effects. The side effects can often be treated or, prevented with other medicines.
Stage I and II tumor treatmentThe chemotherapy agents used for Wilms tumor treatment vary according to stage. Lower stage disease (stages I and II) with favorable histology is usually treated with two chemotherapy medicines, vincristine and dactinomycin. These medicines are given intravenously (into a vein), initially on a weekly schedule and then every 2-3 weeks. Most, if not all of the chemotherapy for stage I-II tumors, is done as an outpatient and the side effects are mild, usually not requiring hospitalization. Radiation therapy is not required in Stages I-II favorable histology disease.
Stage III and IV tumor and unfavorable histology tumor treatmentStage III and IV disease and unfavorable histology tumors, as well as clear cell sarcoma of the kidney and malignant rhabdoid tumor,are treated with 3 or more chemotherapy agents depending on stage and histology. Radiation therapy is given to the abdomen and to other sites of metastases (spread of the cancer). Chemotherapy is given by vein and can usually be given as an outpatient. Occasionally, treatment for these stages of disease requires hospitalization and is often associated with more serious side effects.
Medicines used for higher stage tumors include: vincristine, dactinomycin, doxorubicin, cyclophosfamide, carboplatin, etoposide or ifosfamide (rarely). The choice of medicines used depends on the stage and status of current research treatment protocols.
Radiation TherapyRadiation therapy uses high-energy beams to kill cancer cells. External beam radiation therapy focuses energy onto the cancer using a radiation source outside the body. This type of radiation therapy is often used along with surgery in more advanced cases of Wilms tumor (stages III, IV and V) that have spread beyond the kidney or are not able to be completely removed at surgery. It is used in Stage I and II disease only if there is evidence of unfavorable histology.
Researchers currently DO NOT know what causes Wilms tumor or other kidney tumors.
Researchers design various studies to improve treatment and advance the understanding of cancer and its causes. Clinical trials are carefully reviewed and must be approved through a formal scientific process before anyone can be enrolled. If there is a research study “open” that your child is “eligible for,” you may be asked to allow your child to participate. It is also possible that your child will be asked to participate in more than one study.
Whether an individual is eligible for a particular study may depend on age, location of the cancer, the extent of the disease and other information. Researchers usually must limit their study to some of these characteristics to have a scientifically valid study. Further, researchers must follow exactly the same restrictions throughout the study.
If your child is eligible to participate in one or more study, your doctor will discuss these with you during an initial treatment conference (also called informed consent conference). The doctor will describe the study, potential risks of participation, and other information you need to decide whether or not you would like your child to participate in the study. You always have the choice to participate or not in research studies.
If you do choose to have your child participate in a study, you doctor will explain what type of information you will receive about the results of the study. The overall results of the research study will be published to inform the public and other researchers. No study will publish any information that identifies an individual.
Visit the Clinical Trials section of this website to learn more about the various kinds of research studies.